ANAS BARBARIE HEPATIS ET 30C

Manufacturer
Natural Creations, Inc | OHM Pharma, Inc
Effective date
2022-11-23
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 02:19:27

Label at a glance#

ProductANAS BARBARIE HEPATIS ET 30C
Active ingredientCAIRINA MOSCHATA HEART/LIVER AUTOLYSATE
Label structure10 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

ACTIVE INGREDIENTS (HPUS*): Anas Barbarie Hepatis Et 30C

INDICATIONS & USAGE SECTION

USES: Temporarily relieves symptoms of minor fever and chills.**

OTC - PURPOSE SECTION

USES: Temporarily relieves symptoms of minor fever and chills.**

DOSAGE & ADMINISTRATION SECTION

DIRECTIONS: Adults & children above 12 years: 10 drops orally 3 times daily, or as directed by a health care professional.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF THE REACH OF CHILDREN. In case of overdose (or accidental ingestion) get medical help or contact a Poison Control Center right away.

WARNINGS SECTION

WARNINGS:

  • Consult a physician for use in children under 12 years of age.
  • IF PREGNANT OR BREAST-FEEDING, ask a health care professional before use.
  • KEEP OUT OF THE REACH OF CHILDREN. In case of overdose (or accidental ingestion) get medical help or contact a Poison Control Center right away.
  • Do not use if TAMPER EVIDENT seal is broken or missing.

INACTIVE INGREDIENT SECTION

INACTIVE INGREDIENTS: Ethyl Alcohol USP, Purified Water

OTC - QUESTIONS SECTION

QUESTIONS & COMMENTS?

Natural Creations, Inc. / Woodbine, IA 51579 / 712-647-1600

REFERENCES SECTION

*The letters :HPUS: indicate the component in this product is officially monographed in the Homeopathic Pharmacopeia of the United States.

**Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC: 43406-0661-1

Anas Barbarie Hepatis Et 30C

HOMEOPATHIC

 1fl oz (30mL) / 20% Alcohol

image descriptionimage description

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
43406-0661-12023-01-10C16284748780-1ba0f9c33-15ff-a910-e053-dadaa90a0b85Anas Barbarie Hepatis Et 30C
43406-0661-12021-01-29C16284748780-1ba0f9c33-15ff-a910-e053-dadaa90a0b85Anas Barbarie Hepatis Et 30C

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
43406-0661-1ANAS BARBARIE HEPATIS ET 30C30 mL in 1 BOTTLE, DROPPERLIQUID302

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
43406-0661ANAS BARBARIE HEPATIS ET 30C (ANAS BARBARIE HEPATIS ET) LIQUID [NATURAL CREATIONS, INC]2Current NDC, Legacy NDC, 1 package rows20230111_83230d96-f38c-4013-9382-3ed903fa9c89.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
43406-066143406-0661-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ANAS BARBARIE HEPATIS ET 30CANAS BARBARIE HEPATIS ETNatural Creations, Inc83230d96-f38c-4013-9382-3ed903fa9c892022-11-23WarningsExact identifier
ndc (package): 43406-0661-1
ndc (product): 43406-0661
ndc11 (package): 43406066101
spl id: e996b687-e6a7-4366-a287-b7a96e3fb8bb
spl set id: 83230d96-f38c-4013-9382-3ed903fa9c89

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.